Walleye Capital’s RxSight RXST Stock Holding History

Walleye Capital’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.94M	Buy	314,616 +226,871	+259%	+$1.88M	0.01%	1490
2025 Q4	$914K	Sell	87,745 -50,664	-37%	-$508K	﹤0.01%	2508
2025 Q3	$1.24M	Buy	138,409 +78,051	+129%	+$685K	﹤0.01%	1925
2025 Q2	$785K	Sell	60,358 -137,497	-69%	-$2.07M	﹤0.01%	2250
2025 Q1	$5M	Buy	197,855 +166,513	+531%	+$4.95M	0.02%	785
2024 Q4	$1.08M	Sell	31,342 -98,345	-76%	-$4.44M	﹤0.01%	2320
2024 Q3	$6.41M	Buy	129,687 +111,681	+620%	+$5.72M	0.01%	996
2024 Q2	$1.08M	Sell	18,006 -6,755	-27%	-$386K	﹤0.01%	2757
2024 Q1	$1.28M	Sell	24,761 -66,001	-73%	-$3.24M	﹤0.01%	2354
2023 Q4	$3.66M	Buy	+90,762	New	+$2.66M	0.01%	1316
2023 Q3	–	Sell	-15,679	Closed	-$452K	–	5268
2023 Q2	$452K	Buy	+15,679	New	+$349K	﹤0.01%	2519

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Walleye Capital's RXST Position: Q1 2026 in Review

Walleye Capital increased its RxSight (RXST) stake by 259% in Q1 2026, buying an estimated $1.88M and bringing the position to 314,616 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #1490.

Walleye Capital first reported a position in RXST in Q2 2023 and has held it in 11 quarters since. The position peaked at $6.41M in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Walleye Capital held 314,616 shares of RxSight worth $1.94M as of Q1 2026.
Walleye Capital bought 226,871 RxSight shares in Q1 2026, an estimated $1.88M.
RxSight made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1490 holding.
Walleye Capital first reported a position in RxSight in Q2 2023 and has held it in 11 quarters since.
Walleye Capital's RxSight position peaked at $6.41M in Q3 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.